Eterna Therapeutics
ERNA
ERNA
59 hedge funds and large institutions have $38.4M invested in Eterna Therapeutics in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
26% less capital invested
Capital invested by funds: $52.1M → $38.4M (-$13.6M)
30% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 20
Holders
59
Holding in Top 10
1
Calls
$299K
Puts
$49K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$584K | |
| 3 | +$489K | |
| 4 |
JP Morgan Chase
New York
|
+$450K |
| 5 |
Morgan Stanley
New York
|
+$375K |
Top Sellers
| 1 | -$383K | |
| 2 | -$304K | |
| 3 | -$246K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$156K |
| 5 |
Two Sigma Advisers
New York
|
-$94K |